NM
R New Jersey General Assembly · District 21

Asm. Nancy Muñoz

Compare
Total votes
5,751
all sessions
Attendance
94%
278 missed
Near the chamber average
With party
96%
of cast votes
Lower than 82% of chamber peers
Bipartisan score
3%
crosses aisle rarely
Higher than 82% of chamber peers
Sponsored
819
bills & resolutions
Near the chamber average
Committees
0
assignments
5,751 roll-call votes

Voting record

Yea
4,550
voted in favor
Nay
743
voted against
Absent
278
missed votes
Total cast
5,751
across all sessions
Crossed party
197
votes against own party
This page
5,751
matching current filters
Bill
Description
Vote
Result
Tally
Date
A 3862
Permits professional and occupational licensing boards to expedite licensure of certain individuals during state of emergency or public health emergency.
Yea
Passed
65–0
Mar 16, 2020
A 2280
Criminalizes certain payments for referral of patients to substance use disorder treatment facilities.*
Yea
Passed
12–0
Mar 5, 2020
A 1079
Requires certain health care professionals to undergo explicit and implicit bias training.* Bipartisan
Yea
Passed
10–2
Mar 5, 2020
A 1286
Permits eligible immigrants to obtain professional and occupational licenses in State.*
Other
Passed
5–0
Mar 5, 2020
A 1635
Permits use of telemedicine and telehealth to authorise patients for medical cannabis and to issue written instructions for dispensing medical cannabis.* Bipartisan
Yea
Passed
10–2
Mar 5, 2020
ACR 32
Strongly encourages State Board of Medical Examiners to adopt regulations as necessary to authorize radiologist assistants to practice in New Jersey.
Yea
Passed
8–0
Mar 5, 2020
S 619
Permits use of telemedicine and telehealth to authorize patients for medical cannabis and to issue written instructions for dispensing medical cannabis. * Bipartisan
Yea
Passed
10–2
Mar 5, 2020
A 1194
Provides for temporary travel license to practice chiropractic.
Yea
Passed
8–0
Mar 5, 2020
AJR 22
Designates March as "Multiple System Atrophy Awareness Month."
Yea
Passed
12–0
Mar 5, 2020
A 277
Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Yea
Passed
12–0
Mar 5, 2020
Showing 3,401 to 3,410 of 5,751 votes